Guarnizo S, Karamysheva Z, Galeano E, Muskus C
Cells. 2021; 10(5).
PMID: 33946139
PMC: 8146733.
DOI: 10.3390/cells10051063.
Guarnizo S, Tikhonova E, Zabet-Moghaddam M, Zhang K, Muskus C, Karamyshev A
Microorganisms. 2021; 9(4).
PMID: 33918954
PMC: 8068835.
DOI: 10.3390/microorganisms9040790.
van den Kerkhof M, Sterckx Y, Leprohon P, Maes L, Caljon G
Microorganisms. 2020; 8(6).
PMID: 32599761
PMC: 7356981.
DOI: 10.3390/microorganisms8060950.
Das S, Giri S, Sundar S, Shaha C
Antimicrob Agents Chemother. 2017; 62(1).
PMID: 29061756
PMC: 5740358.
DOI: 10.1128/AAC.00806-17.
Rojo D, Canuto G, Castilho-Martins E, Tavares M, Barbas C, Lopez-Gonzalvez A
PLoS One. 2015; 10(7):e0130675.
PMID: 26161866
PMC: 4498920.
DOI: 10.1371/journal.pone.0130675.
Advances in Development of New Treatment for Leishmaniasis.
De Menezes J, Guedes C, Petersen A, Fraga D, Veras P
Biomed Res Int. 2015; 2015:815023.
PMID: 26078965
PMC: 4442256.
DOI: 10.1155/2015/815023.
Drug resistance analysis by next generation sequencing in Leishmania.
Leprohon P, Fernandez-Prada C, Gazanion E, Monte-Neto R, Ouellette M
Int J Parasitol Drugs Drug Resist. 2015; 5(1):26-35.
PMID: 25941624
PMC: 4412915.
DOI: 10.1016/j.ijpddr.2014.09.005.
MAPK1 of Leishmania donovani modulates antimony susceptibility by downregulating P-glycoprotein efflux pumps.
Garg M, Goyal N
Antimicrob Agents Chemother. 2015; 59(7):3853-63.
PMID: 25870075
PMC: 4468650.
DOI: 10.1128/AAC.04816-14.
The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India.
Singh N, Chatterjee M, Sundar S
Parasit Vectors. 2014; 7:596.
PMID: 25515494
PMC: 4280036.
DOI: 10.1186/s13071-014-0596-1.
Proteomic and genomic analyses of antimony resistant Leishmania infantum mutant.
Brotherton M, Bourassa S, Leprohon P, Legare D, Poirier G, Droit A
PLoS One. 2013; 8(11):e81899.
PMID: 24312377
PMC: 3842243.
DOI: 10.1371/journal.pone.0081899.
Role of efflux pumps and intracellular thiols in natural antimony resistant isolates of Leishmania donovani.
Rai S, Bhaskar , Goel S, Dwivedi U, Sundar S, Goyal N
PLoS One. 2013; 8(9):e74862.
PMID: 24069359
PMC: 3775726.
DOI: 10.1371/journal.pone.0074862.
Moving from unsequenced to sequenced genome: reanalysis of the proteome of Leishmania donovani.
Nirujogi R, Pawar H, Renuse S, Kumar P, Chavan S, Sathe G
J Proteomics. 2013; 97:48-61.
PMID: 23665000
PMC: 4710096.
DOI: 10.1016/j.jprot.2013.04.021.
Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background.
Decuypere S, Vanaerschot M, Brunker K, Imamura H, Muller S, Khanal B
PLoS Negl Trop Dis. 2012; 6(2):e1514.
PMID: 22389733
PMC: 3289598.
DOI: 10.1371/journal.pntd.0001514.
Bioinformatic Analysis of Leishmania donovani Long-Chain Fatty Acid-CoA Ligase as a Novel Drug Target.
Kaur J, Tiwari R, Kumar A, Singh N
Mol Biol Int. 2011; 2011:278051.
PMID: 22091399
PMC: 3198602.
DOI: 10.4061/2011/278051.
Downregulation of mitogen-activated protein kinase 1 of Leishmania donovani field isolates is associated with antimony resistance.
Ashutosh , Garg M, Sundar S, Duncan R, Nakhasi H, Goyal N
Antimicrob Agents Chemother. 2011; 56(1):518-25.
PMID: 22064540
PMC: 3256019.
DOI: 10.1128/AAC.00736-11.
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance.
Downing T, Imamura H, Decuypere S, Clark T, Coombs G, Cotton J
Genome Res. 2011; 21(12):2143-56.
PMID: 22038251
PMC: 3227103.
DOI: 10.1101/gr.123430.111.
Leishmania donovani isolates with antimony-resistant but not -sensitive phenotype inhibit sodium antimony gluconate-induced dendritic cell activation.
Kumar Haldar A, Yadav V, Singhal E, Bisht K, Singh A, Bhaumik S
PLoS Pathog. 2010; 6(5):e1000907.
PMID: 20502630
PMC: 2873921.
DOI: 10.1371/journal.ppat.1000907.
Gene expression modulation is associated with gene amplification, supernumerary chromosomes and chromosome loss in antimony-resistant Leishmania infantum.
Leprohon P, Legare D, Raymond F, Madore E, Hardiman G, Corbeil J
Nucleic Acids Res. 2009; 37(5):1387-99.
PMID: 19129236
PMC: 2655676.
DOI: 10.1093/nar/gkn1069.
Kinetoplastid genomics: the thin end of the wedge.
Sturm N, Martinez L, Thomas S
Infect Genet Evol. 2008; 8(6):901-6.
PMID: 18675383
PMC: 2676795.
DOI: 10.1016/j.meegid.2008.07.001.
Modulation of gene expression in drug resistant Leishmania is associated with gene amplification, gene deletion and chromosome aneuploidy.
Ubeda J, Legare D, Raymond F, Ouameur A, Boisvert S, Rigault P
Genome Biol. 2008; 9(7):R115.
PMID: 18638379
PMC: 2530873.
DOI: 10.1186/gb-2008-9-7-r115.